Journals / Turkish Journal of Anaesthesiology and Reanimation / 2018 / Cilt: 46 - Sayı: 1

Non-Feasibility to Estimate the Need for Reversal of Neuromuscular Relaxation from the Applied Rocuronium Dosing Pattern: A Retrospective Analysis of Anaesthesia Records

Uygulanan Rokuronyum Dozaj Şeklinden Nöromüsküler Bloğu Geri Döndürme Gereksiniminin Tahmin Edilememesi: Anestezi Kayıtlarının Retrospektif Bir Analizi

Pages
57–61
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The dosage profile of rocuronium alone cannot predict the possibility to refrain from pharmacological reversal.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Some anaesthetists are convinced that a long interval since the last relaxant dose may be sufficient to recover from anaesthesia without a pharmacological reversal.
📊
Key Findings & Data:We intended to demonstrate that the dosing pattern of rocuronium could not predict the necessity of reversal.
💡
Conclusion & Impact:Conclusion: The dosage profile of rocuronium alone cannot predict the possibility to refrain from pharmacological reversal.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Some anaesthetists are convinced that a long interval since the last relaxant dose may be sufficient to recover from anaesthesia without a pharmacological reversal. We intended to demonstrate that the dosing pattern of rocuronium could not predict the necessity of reversal. Methods: In a cohort analysis, we retrospectively analysed 180 anaesthesia records of adult patients who underwent elective surgical interventions in general anaesthesia and tracheal intubation with rocuronium-induced neuromuscular blockade. The extracted records were divided to 3 post hoc groups of 60 each, according to the reversal method employed at the end of anaesthesia: group N with neostigmine, group S with sugammadex and group Z without pharmacological reversal. All cases were terminated after achieving a train of four ratio of 0.9. Dosing patterns of rocuronium were compared by applying a novel pharmacometric calculation method, residual drug activity coefficient (RDAC), which employs both the administered individual drug doses in mg kg-1 and the timing of each drug administration in relation to the time of extubation. The rocuronium dosing pattern was correlated with the employed method of neuromuscular blockade reversal. Results: The dosing for rocuronium in patients without pharmacological reversal was lower than that in both reversal agent groups (n=0.58±0.21, S=0.58±0.17 and Z=0.47±0.17), but there was still a large overlap in the RDAC. Conclusion: The dosage profile of rocuronium alone cannot predict the possibility to refrain from pharmacological reversal.

Özet

Amaç: Bazı anestezi uzmanlarına göre, en son uygulanan nöromüsküler bloker dozundan itibaren geçen uzun bir aralık, farmakolojik bir geri dönüş olmaksızın, anesteziden sonra derlenme için yeterlidir. Bu çalışmada amaç rokurunyum dozaj şeklinin, geri dönüş gerekliliğini öngöremediğini göstermektir. Yöntemler: Bu kohort çalışmada, genel anestezi altında elektif cerrahi müdahale ve rokuronyum ile indüklenen nöromusküler blokaj ile trakeal intübasyon uygulanan 180 yetişkin hastanın anestezi kayıtları retrospektif olarak değerlendirildi. Elde edilen kayıtlar, anestezi sonunda uygulanan geri dönüş yöntemine göre her biri 60 kişiden oluşan 3 post hoc gruba ayrıldı: neostigmin kullanılan Grup N, sugammadeks kullanılan Grup S ve farmakolojik geri dönüş kullanılmayan Grup Z. Tüm vakalar "train of four" oranı 0.9 elde edilince sonlandırıldı. Rokuronyumun doz paterni, yeni bir farmakometrik hesaplama metodu (rezidüel ilaç aktivite katsayısı) uygulanarak karşılaştırıldı. Bu katsayı mg kg-1 olarak uygulanan bireysel ilaç dozlarını ve ekstübasyon zamanıyla ilişkili olarak her ilaç uygulama zamanlamasını kullanmaktadır. Rokuronyum dozaj şekli ile uygulanan nöromusküler blokaj geri dönüş yöntemi ile ilişkiliydi. Bulgular: Farmakolojik geri dönüş kullanılmayan hastalarda rokuronyum dozajı, geri dönüş ajanı kullanılan diğer iki gruba göre daha düşüktü (n=0,58±0,21, S=0,58±0,17 ve Z=0,47±0,17). Ancak RDAC değerinde halen büyük bir örtüşüm (overlap) vardı. Sonuç: Tek başına rokuronyum dozaj profili farmakolojik geri dönüşten kaçınma olasılığını öngöremez.

🔖

Cite This Article

BİRO, P., Goltz, K., Dambach, M., Schläpfer, M. (2022). Non-Feasibility to Estimate the Need for Reversal of Neuromuscular Relaxation from the Applied Rocuronium Dosing Pattern: A Retrospective Analysis of Anaesthesia Records. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 46 - Sayı: 1, 57–61. https://ajindex.com/articles/600043

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Arain SR, Kern S, Ficke DJ, Ebert TJ. Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta Anaesthesiol Scand 2005; 49: 312-5. [CrossRef] Fassbender P, Geldner G, Blobner M, Hofmockel R, Rex C, Gautam S, et al. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term. Am J Crit Care 2009; 18: 439-45. [CrossRef] Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111: 129-40. [CrossRef] Eriksson LI, Sundman E, Olsson R, Nilsson L, Witt H, Ekberg O, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43. [CrossRef] Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 120-8. [CrossRef] Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-84. [CrossRef] Biro P. A simple formula for quantification and comparison of systemic drug dosage patterns in the context of application times. Anestezjologia Ratownictwo 2013; 7: 182-4.
  2. Baumuller E, Schaller SJ, Chiquito Lama Y, Frick CG, Bauhofer T, Eikermann M, et al. Postoperative impairment of motor function at train-of-four ratio >/=0.9 cannot be improved by sugammadex (1 mg kg-1). Br J Anaesth 2015; 114: 785-93. [CrossRef] Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103. [CrossRef] Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-8. [CrossRef]